These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 7788891)

  • 41. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis.
    Narcisi EM; Secor WE
    Antimicrob Agents Chemother; 1996 May; 40(5):1121-5. PubMed ID: 8723451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro activity of hexadecylphosphocholine (miltefosine) against metronidazole-resistant and -susceptible strains of Trichomonas vaginalis.
    Blaha C; Duchêne M; Aspöck H; Walochnik J
    J Antimicrob Chemother; 2006 Feb; 57(2):273-8. PubMed ID: 16344287
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Synthesis of new diheterocyclic derivatives of imidazole with antiparasitic activity].
    Quattara L; Debaert M; Cavier R
    Farmaco Sci; 1987 May; 42(5):383-96. PubMed ID: 2886364
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intracellular release of nitric oxide by NCX 972, an NO-releasing metronidazole, enhances in vitro killing of Entamoeba histolytica.
    Sannella A; Gradoni L; Persichini T; Ongini E; Venturini G; Colasanti M
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2303-6. PubMed ID: 12821483
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients.
    Hager WD
    Sex Transm Dis; 2004 Jun; 31(6):343-5. PubMed ID: 15167642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activity of a new nitroimidazole derivative (CP 12 574) on 67 strains of T. vaginalis.
    Miltgen F; Dellenbach P; Kremer M
    Wiad Parazytol; 1973; 19(3):499-501. PubMed ID: 4542510
    [No Abstract]   [Full Text] [Related]  

  • 47. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis.
    Sobel JD; Nyirjesy P; Brown W
    Clin Infect Dis; 2001 Oct; 33(8):1341-6. PubMed ID: 11565074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Studies on the velocity of action of trichomonocidal drugs].
    Broccali G; De Carneri I
    Ginecol Obstet Mex; 1971 Nov; 30(181):481-90. PubMed ID: 5316160
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparative in vitro sensitivity to metronidazole of Trichomonas vaginalis with isolates and clones.
    Sithithaworn P; Sithithaworn J; Kitjaroen K; Pairojkul C; Ratananurakpong S; Sriswangwonk T
    Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):279-84. PubMed ID: 2609217
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic.
    Schmid G; Narcisi E; Mosure D; Secor WE; Higgins J; Moreno H
    J Reprod Med; 2001 Jun; 46(6):545-9. PubMed ID: 11441678
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis.
    Jarrad AM; Debnath A; Miyamoto Y; Hansford KA; Pelingon R; Butler MS; Bains T; Karoli T; Blaskovich MA; Eckmann L; Cooper MA
    Eur J Med Chem; 2016 Sep; 120():353-62. PubMed ID: 27236016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
    Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T
    Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Metronidazole resistance test in vitro in strains of Trichomonas vaginalis isolated from clinical material. 2. Proposal for a standard tests].
    Tachezy J; Kulda J
    Cesk Epidemiol Mikrobiol Imunol; 1991 Mar; 40(2):97-104. PubMed ID: 1827367
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trichomonads, hydrogenosomes and drug resistance.
    Kulda J
    Int J Parasitol; 1999 Feb; 29(2):199-212. PubMed ID: 10221623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of 5-nitroimidazole-resistant trichomonas vaginalis in Oviedo, Spain.
    Pérez S; Fernández-Verdugo A; Pérez F; Vázquez F
    Sex Transm Dis; 2001 Feb; 28(2):115-6. PubMed ID: 11234785
    [No Abstract]   [Full Text] [Related]  

  • 56. Acetarsol pessaries in the treatment of metronidazole resistant Trichomonas vaginalis.
    Chen MY; Smith NA; Fox EF; Bingham JS; Barlow D
    Int J STD AIDS; 1999 Apr; 10(4):277-80. PubMed ID: 12035784
    [No Abstract]   [Full Text] [Related]  

  • 57. Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations.
    Meri T; Jokiranta TS; Suhonen L; Meri S
    J Clin Microbiol; 2000 Feb; 38(2):763-7. PubMed ID: 10655382
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacodynamics of metronidazole determined by a time-kill assay for Trichomonas vaginalis.
    Nix DE; Tyrrell R; Müller M
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1848-52. PubMed ID: 7486930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Metronidazole resistance test in vitro in strains of Trichomonas vaginalis isolated from clinical material. 1. Test conditions].
    Tachezy J; Kulda J
    Cesk Epidemiol Mikrobiol Imunol; 1991 Mar; 40(2):89-96. PubMed ID: 1827366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activities of dicationic compounds against Trichomonas vaginalis.
    Crowell AL; Stephens CE; Kumar A; Boykin DW; Secor WE
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3602-5. PubMed ID: 15328138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.